(S (NP (NP (NNS Studies)) (VP (VBG combining) (NP (NN psychotherapy)) (PP (IN with) (NP (NP (JJ psychedelic) (NNS drugs)) (-LRB- -LRB-) (NP (NNS PsiDs)) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (JJ positive) (NNS outcomes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB often)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS PsiDs) (POS ')) (NN ability) (S (VP (TO to) (VP (VB induce) (NP (NP (NP (NP (`` ') (ADJP (JJ mystical) (HYPH -) (NN type)) ('' ') (NNS experiences)) (-LRB- -LRB-) (NP (NNS MTEs)) (-RRB- -RRB-)) (HYPH -) (NP (ADVP (FW i.e.)) (, ,) (JJ subjective) (NNS experiences))) (SBAR (WHNP (WP$ whose) (NML (NNS characteristics))) (S (VP (VBP include) (NP (NP (DT a) (NN sense)) (PP (IN of) (NP (NN connectedness) (, ,) (NN transcendence) (, ,) (CC and) (NN ineffability)))))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT both) (NNS PsiDs)) (CC and) (NP (JJ virtual) (NN reality))) (VP (MD can) (VP (VB be) (VP (VBN situated) (PP (IN on) (NP (NP (DT a) (JJR broader) (NN spectrum)) (PP (IN of) (NP (JJ psychedelic) (NNS technologies))))))))))) (. .))
(S (S (VP (TO To) (VP (VB test) (NP (DT this) (NN hypothesis))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NNS concepts) (, ,) (NNS methods) (, ,) (CC and) (NN analysis) (NNS strategies)) (PP (IN from) (NP (NN PsiD) (NN research))) (S (VP (TO to) (VP (VB design) (CC and) (VB evaluate) (NP (NP ('' ') (NN Isness) ('' ')) (, ,) (NP (NP (DT a) (NML (NN multi-person) (NN VR)) (NN journey)) (SBAR (WHADVP (WRB where)) (S (NP (NNS participants)) (VP (VBP experience) (NP (NP (DT the) (JJ collective) (NN emergence)) (, ,) (NP (NN fluctuation)) (, ,) (CC and) (NP (NP (NN dissipation)) (PP (IN of) (NP (PRP$ their) (NNS bodies))))) (PP (IN as) (NP (JJ energetic) (NNS essences)))))))))))) (. .))
(S (NP (NP (DT A) (NN study) (PRN (-LRB- -LRB-) (S (NP (NN N)) (VP (SYM =) (NP (CD 57)))) (-RRB- -RRB-))) (VP (VBG analyzing) (NP (NN participant) (NNS responses)) (PP (IN to) (NP (DT a) (ADJP (RB commonly) (VBN used)) (NN PsiD) (NN experience) (NN questionnaire) (PRN (-LRB- -LRB-) (NP (NN MEQ30)) (-RRB- -RRB-)))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN Isness) (NNS participants)) (VP (VBD had) (S (NP (NNS MTEs)) (ADJP (JJ comparable) (PP (IN to) (NP (NP (DT those)) (VP (VBN reported) (PP (IN in) (NP (ADJP (JJ double) (HYPH -) (JJ blind)) (JJ clinical) (NNS studies))) (PP (IN after) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN psilocybin) (CC &) (NN LSD)))))))))))))) (. .))
(S (PP (IN Within) (NP (NP (DT a) (JJ supportive) (NN setting)) (CC and) (NP (JJ conceptual) (NN framework)))) (, ,) (NP (NNP VR) (NN phenomenology)) (VP (MD can) (VP (VB create) (NP (DT the) (NNS conditions)) (PP (IN for) (NP (NP (NNS MTEs)) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (NNS participants)) (VP (VBP derive) (NP (NN insight) (CC and) (NN meaning))))))))) (. .))
